Moderna Vaccine Adolescent Results

8/12/2021 Good news was reported yesterday in the New England Journal of Medicine regarding the safety and efficacy data of Moderna’s COVID 19 vaccine in adolescents.  With over 3,732 patients 12 to 17 years of age there were no serious adverse events and no cases of...

Merck Receives New Vaccine Vaxneuvance™ Approval

7/27/21 The FDA approved last week this newest conjugate vaccine pneumococcal 15-valent, Vaxneuvance™ manufactured by Merck. Now, finally more vaccine options are available for the prevention of invasive pneumoccocal disease caused by Streptococcus...

Prevnar 20 Wins FDA Approval!

6/9/21 Pfizer’s conjugated pneumonia vaccine #PCV20 just approved!  Physicians and medical groups needing access to discount pricing on Pfizer vaccines as well as Merck, Sanofi Pasteur and AstraZeneca may do so through a free MPPG membership. Join MPPG...